# Purdue Pharmaceuticals LP - Inspection Records

Source: https://www.keypedia.com/companies/purdue-pharmaceuticals-lp/404112a8-6b5a-4bea-9890-9c5f6339ca44

> Inspection records and compliance data for Purdue Pharmaceuticals LP in Wilson, North Carolina. Access full analysis and detailed observations.

---

## Details

- Name: Purdue Pharmaceuticals LP
- FEI Number: 3002960808
- City: Wilson
- State: North Carolina
- Country Name: United States
- Address Line 1: 4701 International Blvd
- Zip Code: 27893
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [483 - Purdue Pharmaceuticals LP - 2022-08-11](https://www.keypedia.com/records/483/purdue-pharmaceuticals-lp/372c0650-56a8-4ac0-b1ec-b6acca464f95) — source: FDA, date: August 11, 2022
- [FDA Inspection 1178224 - Purdue Pharmaceuticals LP - 2022-08-11](https://www.keypedia.com/records/fda_inspections/purdue-pharmaceuticals-lp/1d7d0437-a69f-4578-a184-eed521ea55d7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 11, 2022
- [483 - Purdue Pharmaceuticals LP - 2019-12-19](https://www.keypedia.com/records/483/purdue-pharmaceuticals-lp/40ab1419-91d2-40cf-ac2f-92c939187f63) — source: FDA, date: December 19, 2019
- [FDA Inspection 1113735 - Purdue Pharmaceuticals LP - 2019-12-19](https://www.keypedia.com/records/fda_inspections/purdue-pharmaceuticals-lp/4b966855-9072-4061-a107-40808e0ea1da) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 19, 2019
- [FDA Inspection 1028417 - Purdue Pharmaceuticals LP - 2017-08-24](https://www.keypedia.com/records/fda_inspections/purdue-pharmaceuticals-lp/8f13dabb-35a4-4b7f-af92-b160eb55866b) — classification: No Action Indicated (NAI), source: FDA, date: August 24, 2017
- [FDA Inspection 888629 - Purdue Pharmaceuticals LP - 2014-07-17](https://www.keypedia.com/records/fda_inspections/purdue-pharmaceuticals-lp/a2e921d2-419e-402b-8984-4487a76712d4) — classification: No Action Indicated (NAI), source: FDA, date: July 17, 2014
- [FDA Inspection 860931 - Purdue Pharmaceuticals LP - 2013-11-08](https://www.keypedia.com/records/fda_inspections/purdue-pharmaceuticals-lp/bce1ada2-39b8-49fc-93a0-7e76d887172c) — classification: No Action Indicated (NAI), source: FDA, date: November 8, 2013
- [FDA Inspection 708668 - Purdue Pharmaceuticals LP - 2011-01-27](https://www.keypedia.com/records/fda_inspections/purdue-pharmaceuticals-lp/75f1abf3-794a-4ed8-8a06-cb6ed566b614) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 27, 2011

## Related Companies

- [Buckeye International Inc](https://www.keypedia.com/companies/buckeye-international-inc/01799cae-da24-4d86-9a28-d25a72c9bc8b)
- [Spectrum Pharmaceuticals, Inc.](https://www.keypedia.com/companies/spectrum-pharmaceuticals-inc/d2be8240-3764-497f-8d0d-fbedb45f3053)
- [G S Cosmeceutical USA Inc](https://www.keypedia.com/companies/g-s-cosmeceutical-usa-inc/02e5e566-9934-4417-9659-f041ee537843)
- [Columbia Cosmetics Manufacturing, Inc.](https://www.keypedia.com/companies/columbia-cosmetics-manufacturing-inc/c6e32c25-080a-4901-8391-8716d6517687)
- [Instituto Grifols, S.A.](https://www.keypedia.com/companies/instituto-grifols-sa/478ef862-9ed8-4172-919f-c7475c316b61)
- [Delcath Systems Inc.](https://www.keypedia.com/companies/delcath-systems-inc/ce3ea8cb-f842-43a9-9eb4-91e58e74932b)
- [Dixon Investments Inc](https://www.keypedia.com/companies/dixon-investments-inc/ce191609-e6f1-4391-8f04-21996703095d)
- [Marksans Pharma Limited](https://www.keypedia.com/companies/marksans-pharma-limited/0855d225-2181-468a-a51c-c479608c1c92)
- [InvaDerm, Inc.](https://www.keypedia.com/companies/invaderm-inc/33416b4a-1d16-4adf-987e-d5970ac5f9a2)
- [Evi Labs](https://www.keypedia.com/companies/evi-labs/0713d12b-117d-4b0b-a25e-2df2a5682fc4)

## Related Officers

- [Libia Lugo](https://www.keypedia.com/people/libia-lugo/55f1387e-b6bd-41ca-8507-45829629dac5)
- [Pratik S. Upadhyay](https://www.keypedia.com/people/pratik-s-upadhyay/22ff2e0b-17d4-4c91-a3f0-c7e30b7a115b)